Insights into Skeletal Muscle Development and Applications in Regenerative Medicine

International Review of Cell and Molecular Biology

Volumn 300, Issue , 2013, Pages 51-83

  Tran, T ^a   Andersen, R ^a   Sherman, S P ^a,b   Pyle, A D ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Embryonic development; Embryonic stem cells; Myogenic cells; Regenerative medicine; Skeletal muscle; Transcriptional regulation

Indexed keywords

5' NUCLEOTIDASE; ANTISENSE OLIGONUCLEOTIDE; BONE MORPHOGENETIC PROTEIN; CADHERIN; CD34 ANTIGEN; DYSTROPHIN; MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 206; MITOGEN ACTIVATED PROTEIN KINASE; MYOD PROTEIN; MYOGENIC FACTOR 5; MYOGENIN; OCTAMER TRANSCRIPTION FACTOR 4; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR RECEPTOR; SERUM RESPONSE FACTOR; SMAD3 PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR PAX3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

AGING; ARTICLE; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELECTION; DUCHENNE MUSCULAR DYSTROPHY; EMBRYO DEVELOPMENT; EMBRYOID BODY; EXPERIMENTAL MODEL; HUMAN; MEMBRANE STRUCTURE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; MYOTOME; NONHUMAN; OXYGEN CONSUMPTION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; STEM CELL NICHE; STEM CELL TRANSPLANTATION; TELOMERE;

ANIMALIA;

EID: 84871671645     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-405210-9.00002-3     Document Type: Chapter

References (159)

1. Alderton J.M., Steinhardt R.A. Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. J. Biol. Chem. 2000, 275:9452-9460.
2. Alway S.E., Degens H., Lowe D.A., Krishnamurthy G. Increased myogenic repressor Id mRNA and protein levels in hindlimb muscles of aged rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R411-R422.
3. Armand O., Boutineau A.M., Mauger A., Pautou M.P., Kieny M. Origin of satellite cells in avian skeletal muscles. Arch. Anat. Microsc. Morphol. Exp. 1983, 72:163-181.
4. Armulik A., Abramsson A., Betsholtz C. Endothelial/pericyte interactions. Circ. Res. 2005, 97:512-523.
5. Asakura A., Seale P., Girgis-Gabardo A., Rudnicki M.A. Myogenic specification of side population cells in skeletal muscle. J. Cell Biol. 2002, 159:123-134.
6. Bachrach E., Li S., Perez A.L., Schienda J., Liadaki K., Volinski J., Flint A., Chamberlain J., Kunkel L.M. Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3581-3586.
7. Bajard L., Relaix F., Lagha M., Rocancourt D., Daubas P., Buckingham M.E. A novel genetic hierarchy functions during hypaxial myogenesis: Pax3 directly activates Myf5 in muscle progenitor cells in the limb. Genes Dev. 2006, 20:2450-2464.
8. Barberi T., Bradbury M., Dincer Z., Panagiotakos G., Socci N.D., Studer L. Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat. Med. 2007, 13:642-648.
9. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
10. Beauchamp J.R., Heslop L., Yu D.S., Tajbakhsh S., Kelly R.G., Wernig A., Buckingham M.E., Partridge T.A., Zammit P.S. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J. Cell Biol. 2000, 151:1221-1234.
11. Bentzinger C.F., von Maltzahn J., Rudnicki M.A. Extrinsic regulation of satellite cell specification. Stem Cell Res. Ther. 2010, 1:27.
12. Bentzinger C.F., Wang Y.X., Rudnicki M.A. Building muscle: molecular regulation of myogenesis. Cold Spring Harb. Perspect. Biol. 2012, 4.
13. Bhagavati S., Xu W. Generation of skeletal muscle from transplanted embryonic stem cells in dystrophic mice. Biochem. Biophys. Res. Commun. 2005, 333:644-649.
14. Bigot A., Jacquemin V., Debacq-Chainiaux F., Butler-Browne G.S., Toussaint O., Furling D., Mouly V. Replicative aging down-regulates the myogenic regulatory factors in human myoblasts. Biol. Cell 2008, 100:189-199.
15. Biressi S., Molinaro M., Cossu G. Cellular heterogeneity during vertebrate skeletal muscle development. Dev. Biol. 2007, 308:281-293.
16. Bischoff R. Regeneration of single skeletal muscle fibers in vitro. Anat. Rec. 1975, 182:215-235.
17. Brack A.S., Conboy I.M., Conboy M.J., Shen J., Rando T.A. A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2008, 2:50-59.
18. Brack A.S., Conboy M.J., Roy S., Lee M., Kuo C.J., Keller C., Rando T.A. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007, 317:807-810.
19. Brustle O., Spiro A.C., Karram K., Choudhary K., Okabe S., McKay R.D. In vitro-generated neural precursors participate in mammalian brain development. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:14809-14814.
20. Buckingham M. Muscle differentiation. Which myogenic factors make muscle?. Curr. Biol. 1994, 4:61-63.
21. Bulfield G., Siller W.G., Wight P.A., Moore K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:1189-1192.
22. Buttery L.D., Bourne S., Xynos J.D., Wood H., Hughes F.J., Hughes S.P., Episkopou V., Polak J.M. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng. 2001, 7:89-99.
23. Carlson B.M., Dedkov E.I., Borisov A.B., Faulkner J.A. Skeletal muscle regeneration in very old rats. J. Gerontol. A Biol. Sci. Med. Sci. 2001, 56:B224-B233.
24. Carlson B.M., Faulkner J.A. Muscle transplantation between young and old rats: age of host determines recovery. Am. J. Physiol. 1989, 256:C1262-C1266.
25. Carlson M.E., Hsu M., Conboy I.M. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 2008, 454:528-532.
26. Carlson M.E., Suetta C., Conboy M.J., Aagaard P., Mackey A., Kjaer M., Conboy I. Molecular aging and rejuvenation of human muscle stem cells. EMBO Mol. Med. 2009, 1:381-391.
27. Cerletti M., Jurga S., Witczak C.A., Hirshman M.F., Shadrach J.L., Goodyear L.J., Wagers A.J. Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 2008, 134:37-47.
28. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., Conlon F.L., Wang D.Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38:228-233.
29. Christ B., Brand-Saberi B., Grim M., Wilting J. Local signalling in dermomyotomal cell type specification. Anat. Embryol. (Berl) 1992, 186:505-510.
30. Christ B., Ordahl C.P. Early stages of chick somite development. Anat. Embryol. (Berl) 1995, 191:381-396.
31. Collins C.A., Morgan J.E. Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies. Int. J. Exp. Pathol. 2003, 84:165-172.
32. Collins C.A., Zammit P.S., Ruiz A.P., Morgan J.E., Partridge T.A. A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells 2007, 25:885-894.
33. Conboy I.M., Conboy M.J., Smythe G.M., Rando T.A. Notch-mediated restoration of regenerative potential to aged muscle. Science 2003, 302:1575-1577.
34. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433:760-764.
35. Conboy I.M., Rando T.A. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell 2002, 3:397-409.
36. Cooper B.J., Winand N.J., Stedman H., Valentine B.A., Hoffman E.P., Kunkel L.M., Scott M.O., Fischbeck K.H., Kornegay J.N., Avery R.J. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 1988, 334:154-156.
37. Corbu A., Scaramozza A., Badiali-DeGiorgi L., Tarantino L., Papa V., Rinaldi R., D'Alessandro R., Zavatta M., Laus M., Lattanzi G., Cenacchi G. Satellite cell characterization from aging human muscle. Neurol Res. 2010, 32(1):63-72.
38. Cornelison D.D., Wold B.J. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 1997, 191:270-283.
39. Cossu G., Borello U. Wnt signaling and the activation of myogenesis in mammals. EMBO J. 1999, 18:6867-6872.
40. Cossu G., Kelly R., Di Donna S., Vivarelli E., Buckingham M. Myoblast differentiation during mammalian somitogenesis is dependent upon a community effect. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:2254-2258.
41. Cossu G., Sampaolesi M. New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol. Med. 2007, 13:520-526.
42. Cossu G., Tajbakhsh S., Buckingham M. How is myogenesis initiated in the embryo?. Trends Genet. 1996, 12:218-223.
43. Crescenzi M., Fleming T.P., Lassar A.B., Weintraub H., Aaronson S.A. MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:8442-8446.
44. Darabi R., Gehlbach K., Bachoo R.M., Kamath S., Osawa M., Kamm K.E., Kyba M., Perlingeiro R.C. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat. Med. 2008, 14:134-143.
45. De Angelis L., Berghella L., Coletta M., Lattanzi L., Zanchi M., Cusella-De Angelis M.G., Ponzetto C., Cossu G. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J. Cell Biol. 1999, 147:869-878.
46. Decary S., Hamida C.B., Mouly V., Barbet J.P., Hentati F., Butler-Browne G.S. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul. Disord. 2000, 10:113-120.
47. Dellavalle A., Sampaolesi M., Tonlorenzi R., Tagliafico E., Sacchetti B., Perani L., Innocenzi A., Galvez B.G., Messina G., Morosetti R., et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 2007, 9:255-267.
48. Di Rocco G., Iachininoto M.G., Tritarelli A., Straino S., Zacheo A., Germani A., Crea F., Capogrossi M.C. Myogenic potential of adipose-tissue-derived cells. J. Cell Sci. 2006, 119:2945-2952.
49. Doetschman T.C., Eistetter H., Katz M., Schmidt W., Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 1985, 87:27-45.
50. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
51. Ervasti J.M., Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 1993, 122:809-823.
52. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
53. Fan Y., Maley M., Beilharz M., Grounds M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 1996, 19:853-860.
54. Ferrari G., Cusella-De Angelis G., Coletta M., Paolucci E., Stornaiuolo A., Cossu G., Mavilio F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998, 279:1528-1530.
55. Fujikawa T., Oh S.H., Pi L., Hatch H.M., Shupe T., Petersen B.E. Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am. J. Pathol. 2005, 166:1781-1791.
56. Fukada S., Higuchi S., Segawa M., Koda K., Yamamoto Y., Tsujikawa K., Kohama Y., Uezumi A., Imamura M., Miyagoe-Suzuki Y., et al. Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Exp. Cell Res. 2004, 296:245-255.
57. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 1996, 183:1797-1806.
58. Grady R.M., Teng H., Nichol M.C., Cunningham J.C., Wilkinson R.S., Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 1997, 90:729-738.
59. Gros J., Manceau M., Thome V., Marcelle C. A common somitic origin for embryonic muscle progenitors and satellite cells. Nature 2005, 435:954-958.
60. Gurdon J.B. A community effect in animal development. Nature 1988, 336:772-774.
61. Gussoni E., Pavlath G.K., Lanctot A.M., Sharma K.R., Miller R.G., Steinman L., Blau H.M. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 1992, 356:435-438.
62. Gussoni E., Soneoka Y., Strickland C.D., Buzney E.A., Khan M.K., Flint A.F., Kunkel L.M., Mulligan R.C. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999, 401:390-394.
63. Harel I., Nathan E., Tirosh-Finkel L., Zigdon H., Guimaraes-Camboa N., Evans S.M., Tzahor E. Distinct origins and genetic programs of head muscle satellite cells. Dev. Cell 2009, 16:822-832.
64. Hawke T.J., Garry D.J. Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 2001, 91:534-551.
65. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
66. Huard J., Acsadi G., Jani A., Massie B., Karpati G. Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 1994, 5:949-958.
67. Huard J., Bouchard J.P., Roy R., Malouin F., Dansereau G., Labrecque C., Albert N., Richards C.L., Lemieux B., Tremblay J.P. Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 1992, 15:550-560.
68. Jones N.C., Tyner K.J., Nibarger L., Stanley H.M., Cornelison D.D.W., Fedorov Y.V., Olwin B.B. The p38alpha/beta MAPK functions as a molecular switch to activate the quiescent satellite cell. J. Cell Biol. 2005, 169:105-116.
69. Karpati G., Ajdukovic D., Arnold D., Gledhill R.B., Guttmann R., Holland P., Koch P.A., Shoubridge E., Spence D., Vanasse M., et al. Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 1993, 34:8-17.
70. Kassar-Duchossoy L., Gayraud-Morel B., Gomes D., Rocancourt D., Buckingham M., Shinin V., Tajbakhsh S. Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. Nature 2004, 431:466-471.
71. Kassar-Duchossoy L., Giacone E., Gayraud-Morel B., Jory A., Gomes D., Tajbakhsh S. Pax3/Pax7 mark a novel population of primitive myogenic cells during development. Genes Dev. 2005, 19:1426-1431.
72. Kataoka H., Takakura N., Nishikawa S., Tsuchida K., Kodama H., Kunisada T., Risau W., Kita T., Nishikawa S.I. Expressions of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells. Dev. Growth Differ. 1997, 39:729-740.
73. Kim H.K., Lee Y.S., Sivaprasad U., Malhotra A., Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J. Cell Biol. 2006, 174:677-687.
74. Kipling D., Cooke H.J. Hypervariable ultra-long telomeres in mice. Nature 1990, 347:400-402.
75. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987, 50:509-517.
76. Konigsberg I.R. The differentiation of cross-striated myofibrils in short term cell culture. Exp. Cell Res. 1960, 21:414-420.
77. Konigsberg U.R., Lipton B.H., Konigsberg I.R. The regenerative response of single mature muscle fibers isolated in vitro. Dev. Biol. 1975, 45:260-275.
78. Kuang S., Chargé S.B., Seale P., Huh M., Rudnicki M.A. Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J. Cell Biol. 2006, 172:103-113.
79. Kuang S., Kuroda K., Le Grand F., Rudnicki M.A. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 2007, 129:999-1010.
80. Lash J.W., Holtzer H., Swift H. Regeneration of mature skeletal muscle. Anat. Rec. 1957, 128:679-697.
81. Law P.K., Bertorini T.E., Goodwin T.G., Chen M., Fang Q.W., Li H.J., Kirby D.S., Florendo J.A., Herrod H.G., Golden G.S. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 1990, 336:114-115.
82. Leahy A., Xiong J.W., Kuhnert F., Stuhlmann H. Use of developmental marker genes to define temporal and spatial patterns of differentiation during embryoid body formation. J. Exp. Zool. 1999, 284:67-81.
83. Lee J.H., Kemp D.M. Human adipose-derived stem cells display myogenic potential and perturbed function in hypoxic conditions. Biochem. Biophys. Res. Commun. 2006, 341:882-888.
84. Leon-Quinto T., Jones J., Skoudy A., Burcin M., Soria B. In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. Diabetologia 2004, 47:1442-1451.
85. Lepper C., Conway S.J., Fan C.M. Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements. Nature 2009, 460:627-631.
86. Liu N., Williams A.H., Kim Y., McAnally J., Bezprozvannaya S., Sutherland L.B., Richardson J.A., Bassel-Duby R., Olson E.N. An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:20844-20849.
87. Maroto M., Reshef R., Munsterberg A.E., Koester S., Goulding M., Lassar A.B. Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell 1997, 89:139-148.
88. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:7634-7638.
89. Mastroyiannopoulos N.P., Nicolaou P., Anayasa M., Uney J.B., Phylactou L.A. Down-regulation of myogenin can reverse terminal muscle cell differentiation. PLoS One 2012, 7. e29896.
90. Mauro A. Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 1961, 9:493-495.
91. Megeney L.A., Rudnicki M.A. Determination versus differentiation and the MyoD family of transcription factors. Biochem. Cell Biol. 1995, 73:723-732.
92. Mendell J.R., Kissel J.T., Amato A.A., King W., Signore L., Prior T.W., Sahenk Z., Benson S., McAndrew P.E., Rice R., et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 1995, 333:832-838.
93. Mennerich D., Braun T. Activation of myogenesis by the homeobox gene Lbx1 requires cell proliferation. EMBO J. 2001, 20:7174-7183.
94. Messina G., Sirabella D., Monteverde S., Galvez B.G., Tonlorenzi R., Schnapp E., De Angelis L., Brunelli S., Relaix F., Buckingham M., et al. Skeletal muscle differentiation of embryonic mesoangioblasts requires pax3 activity. Stem Cells 2009, 27:157-164.
95. Minasi M.G., Riminucci M., De Angelis L., Borello U., Berarducci B., Innocenzi A., Caprioli A., Sirabella D., Baiocchi M., De Maria R., et al. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 2002, 129:2773-2783.
96. Mizuno Y., Chang H., Umeda K., Niwa A., Iwasa T., Awaya T., Fukada S., Yamamoto H., Yamanaka S., Nakahata T., et al. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J. 2010, 24:2245-2253.
97. Molkentin J.D., Olson E.N. Defining the regulatory networks for muscle development. Curr. Opin. Genet. Dev. 1996, 6:445-453.
98. Montarras D., Morgan J., Collins C., Relaix F., Zaffran S., Cumano A., Partridge T., Buckingham M. Direct isolation of satellite cells for skeletal muscle regeneration. Science 2005, 309:2064-2067.
99. Moore S.E., Walsh F.S. Specific regulation of N-CAM/D2-CAM cell adhesion molecule during skeletal muscle development. EMBO J. 1985, 4:623-630.
100. Morandi L., Bernasconi P., Gebbia M., Mora M., Crosti F., Mantegazza R., Cornelio F. Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer. Neuromuscul. Disord. 1995, 5:291-295.
101. Munsterberg A.E., Lassar A.B. Combinatorial signals from the neural tube, floor plate and notochord induce myogenic bHLH gene expression in the somite. Development 1995, 121:651-660.
102. Myer A., Olson E.N., Klein W.H. MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells. Dev. Biol. 2001, 229:340-350.
103. Nabeshima Y., Hanaoka K., Hayasaka M., Esumi E., Li S., Nonaka I. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 1993, 364:532-535.
104. Nagata Y., Partridge T.A., Matsuda R., Zammit P.S. Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. J. Cell Biol. 2006, 174:245-253.
105. Nelson S.F., Crosbie R.H., Miceli M.C., Spencer M.J. Emerging genetic therapies to treat Duchenne muscular dystrophy. Curr. Opin. Neurol. 2009, 22:532-538.
106. O'Connor M.S., Carlson M.E., Conboy I.M. Differentiation rather than aging of muscle stem cells abolishes their telomerase activity. Biotechnol. Prog. 2009, 25:1130-1137.
107. Odorico J.S., Kaufman D.S., Thomson J.A. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001, 19:193-204.
108. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
109. Ono Y., Boldrin L., Knopp P., Morgan J.E., Zammit P.S. Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles. Dev. Biol. 2010, 337:29-41.
110. Partridge T.A., Grounds M., Sloper J.C. Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 1978, 273:306-308.
111. Pavlath G.K., Thaloor D., Rando T.A., Cheong M., English A.W., Zheng B. Heterogeneity among muscle precursor cells in adult skeletal muscles with differing regenerative capacities. Dev. Dyn. 1998, 212:495-508.
112. Porter J.D., Israel S., Gong B., Merriam A.P., Feuerman J., Khanna S., Kaminski H.J. Distinctive morphological and gene/protein expression signatures during myogenesis in novel cell lines from extraocular and hindlimb muscle. Physiol. Genomics 2006, 24:264-275.
113. Pownall M.E., Strunk K.E., Emerson C.P. Notochord signals control the transcriptional cascade of myogenic bHLH genes in somites of quail embryos. Development 1996, 122:1475-1488.
114. Price F.D., Kuroda K., Rudnicki M.A. Stem cell based therapies to treat muscular dystrophy. Biochim. Biophys. Acta 2007, 1772:272-283.
115. Qu Z., Balkir L., van Deutekom J.C., Robbins P.D., Pruchnic R., Huard J. Development of approaches to improve cell survival in myoblast transfer therapy. J. Cell Biol. 1998, 142:1257-1267.
116. Qu-Petersen Z., Deasy B., Jankowski R., Ikezawa M., Cummins J., Pruchnic R., Mytinger J., Cao B., Gates C., Wernig A., et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J. Cell Biol. 2002, 157:851-864.
117. Rando T.A., Blau H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 1994, 125:1275-1287.
118. Rathjen J., Rathjen P.D. Mouse ES cells: experimental exploitation of pluripotent differentiation potential. Curr. Opin. Genet. Dev. 2001, 11:587-594.
119. Raue U., Slivka D., Jemiolo B., Hollon C., Trappe S. Myogenic gene expression at rest and after a bout of resistance exercise in young (18-30 yr) and old (80-89 yr) women. J. Appl. Physiol. 2006, 101:53-59.
120. Relaix F., Montarras D., Zaffran S., Gayraud-Morel B., Rocancourt D., Tajbakhsh S., Mansouri A., Cumano A., Buckingham M. Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. J. Cell Biol. 2006, 172:91-102.
121. Relaix F., Rocancourt D., Mansouri A., Buckingham M. A Pax3/Pax7-dependent population of skeletal muscle progenitor cells. Nature 2005, 435:948-953.
122. Renault V., Thornell L.-E., Butler-Browne G., Mouly V. Human skeletal muscle satellite cells: aging, oxidative stress and the mitotic clock. Exp. Gerontol. 2002, 37:1229-1236.
123. Richler C., Yaffe D. The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev. Biol. 1970, 23:1-22.
124. Rohwedel J., Maltsev V., Bober E., Arnold H.H., Hescheler J., Wobus A.M. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev. Biol. 1994, 164:87-101.
125. Rudnicki M.A., Schnegelsberg P.N., Stead R.H., Braun T., Arnold H.H., Jaenisch R. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993, 75:1351-1359.
126. Sacco A., Mourkioti F., Tran R., Choi J., Llewellyn M., Kraft P., Shkreli M., Delp S., Pomerantz J.H., Artandi S.E., et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 2010, 143:1059-1071.
127. Sampaolesi M., Blot S., D'Antona G., Granger N., Tonlorenzi R., Innocenzi A., Mognol P., Thibaud J.L., Galvez B.G., Barthelemy I., et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006, 444:574-579.
128. Schienda J., Engleka K.A., Jun S., Hansen M.S., Epstein J.A., Tabin C.J., Kunkel L.M., Kardon G. Somitic origin of limb muscle satellite and side population cells. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:945-950.
129. Seale P., Bjork B., Yang W., Kajimura S., Chin S., Kuang S., Scime A., Devarakonda S., Conroe H.M., Erdjument-Bromage H., et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008, 454:961-967.
130. Seale P., Sabourin L.A., Girgis-Gabardo A., Mansouri A., Gruss P., Rudnicki M.A. Pax7 is required for the specification of myogenic satellite cells. Cell 2000, 102:777-786.
131. Shefer G., Van de Mark D.P., Richardson J.B., Yablonka-Reuveni Z. Satellite-cell pool size does matter: defining the myogenic potency of aging skeletal muscle. Dev. Biol. 2006, 294:50-66.
132. Sherwood R.I., Christensen J.L., Conboy I.M., Conboy M.J., Rando T.A., Weissman I.L., Wagers A.J. Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 2004, 119:543-554.
133. Sicinski P., Geng Y., Ryder-Cook A.S., Barnard E.A., Darlison M.G., Barnard P.J. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 1989, 244:1578-1580.
134. Smythe G.M., Grounds M.D. Exposure to tissue culture conditions can adversely affect myoblast behavior in vivo in whole muscle grafts: implications for myoblast transfer therapy. Cell Transplant. 2000, 9:379-393.
135. Smythe G.M., Hodgetts S.I., Grounds M.D. Immunobiology and the future of myoblast transfer therapy. Mol. Ther. 2000, 1:304-313.
136. Sommer C.A., Sommer A.G., Longmire T.A., Christodoulou C., Thomas D.D., Gostissa M., Alt F.W., Murphy G.J., Kotton D.N., Mostoslavsky G. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 2010, 28:64-74.
137. Stedman H.H., Sweeney H.L., Shrager J.B., Maguire H.C., Panettieri R.A., Petrof B., Narusawa M., Leferovich J.M., Sladky J.T., Kelly A.M. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991, 352:536-539.
138. Sunada Y., Bernier S.M., Kozak C.A., Yamada Y., Campbell K.P. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J. Biol. Chem. 1994, 269:13729-13732.
139. Tajbakhsh S., Bober E., Babinet C., Pournin S., Arnold H., Buckingham M. Gene targeting the myf-5 locus with nlacZ reveals expression of this myogenic factor in mature skeletal muscle fibres as well as early embryonic muscle. Dev. Dyn. 1996, 206:291-300.
140. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
141. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
142. Tanaka K.K., Hall J.K., Troy A.A., Cornelison D.D., Majka S.M., Olwin B.B. Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell 2009, 4:217-225.
143. Taylor-Jones J.M., McGehee R.E., Rando T.A., Lecka-Czernik B., Lipschitz D.A., Peterson C.A. Activation of an adipogenic program in adult myoblasts with age. Mech. Ageing Dev. 2002, 123:649-661.
144. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
145. Tinsley J.M., Potter A.C., Phelps S.R., Fisher R., Trickett J.I., Davies K.E. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 1996, 384:349-353.
146. Tremblay J.P., Malouin F., Roy R., Huard J., Bouchard J.P., Satoh A., Richards C.L. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 1993, 2:99-112.
147. Valentine B.A., Cooper B.J., de Lahunta A., O'Quinn R., Blue J.T. Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. J. Neurol. Sci. 1988, 88:69-81.
148. Valentine B.A., Winand N.J., Pradhan D., Moise N.S., de Lahunta A., Kornegay J.N., Cooper B.J. Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review. Am. J. Med. Genet. 1992, 42:352-356.
149. Walsh F.S., Ritter M.A. Surface antigen differentiation during human myogenesis in culture. Nature 1981, 289:60-64.
150. Webster C., Blau H.M. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somat. Cell Mol. Genet. 1990, 16:557-565.
151. Welch E.M., Barton E.R., Zhuo J., Tomizawa Y., Friesen W.J., Trifillis P., Paushkin S., Patel M., Trotta C.R., Hwang S., et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature 2007, 447:87-91.
152. Wernig A., Schäfer R., Knauf U., Mundegar R.R., Zweyer M., Högemeier O., Martens U.M., Zimmermann S. On the regenerative capacity of human skeletal muscle. Artif. Organs 2005, 29:192-198.
153. Williams A.H., Liu N., van Rooij E., Olson E.N. MicroRNA control of muscle development and disease. Curr. Opin. Cell Biol. 2009, 21:461-469.
154. Wu B., Li Y., Morcos P.A., Doran T.J., Lu P., Lu Q.L. Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice. Mol. Ther. 2009, 17:864-871.
155. Xu H., Wu X.R., Wewer U.M., Engvall E. Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene. Nat. Genet. 1994, 8:297-302.
156. Young A.P., Wagers A.J. Pax3 induces differentiation of juvenile skeletal muscle stem cells without transcriptional upregulation of canonical myogenic regulatory factors. J. Cell Sci. 2010, 123:2632-2639.
157. Zhao Y., Samal E., Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436:214-220.
158. Zou J., Maeder M.L., Mali P., Pruett-Miller S.M., Thibodeau-Beganny S., Chou B.K., Chen G., Ye Z., Park I.H., Daley G.Q., et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 2009, 5:97-110.
159. Zwaka T.P., Thomson J.A. Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 2003, 21:319-321.